Spanish team isolates hepatitis G virus:
This article was originally published in Clinica
Executive Summary
A research team from the Jimenez Diaz Foundation in Madrid, Spain, has isolated and cloned the hepatitis G virus in serum from Spanish patients. The virus has also been detected in patients in Austria, Germany, Greece, Peru, the US and the UK, says El Pais. Dr Vicente Carreno, who led the Spanish team, believes his results may show that HGV acts as a co-factor worsening infections caused by other hepatitis viruses. In the Spanish study, HGV was detected in 10 of 56 patients with chronic viral hepatitis.
You may also be interested in...
Lannett Plans Seven Launches In Fiscal Year 2021
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer Picks Up EU Pegfilgrastim Approval
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
A Stroke Of Luck Boosts Oxford/AZ’s “Vaccine For The World”
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: